If you or a family member were prescribed the psychiatric medication Rexulti in Canada, you have only days left to claim potential compensation from a multi-million-dollar court settlement.
The Superior Court of Quebec approved a nationwide $4.75-million class-action settlement resolving allegations that the makers of Rexulti failed to warn patients and doctors about severe, life-altering impulse control side effects. The deadline to file a claim package—Monday, July 27, 2026—is fast approaching.
For Canadians who experienced uncharacteristic behavioral changes while taking the drug, including uncontrollable gambling, compulsive spending, binge eating, or hypersexuality, this deadline marks the final opportunity to secure a financial payout. Here is a look at what the lawsuit alleged, who qualifies for compensation, and the exact steps you need to take before time runs out.
The Allegations: Unwarned Behavioral Risks and Impulse Control Issues
The underlying class-action lawsuit was originally filed by the law firm Rochon Genova against drug manufacturers Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc. The Superior Court of Quebec authorized the national class proceeding on December 3, 2021.
At the center of the legal dispute are claims that Rexulti—an atypical antipsychotic medication prescribed to treat schizophrenia and as an add-on treatment for major depressive disorder—can trigger or severely exacerbate impulse control disorders.
According to court filings, plaintiffs alleged that taking Rexulti caused patients to engage in intense, uncontrollable urges, specifically:
- Compulsive or pathological gambling
- Hypersexuality
- Binge eating
- Uncontrollable or compulsive shopping and spending
The lawsuit contended that the pharmaceutical companies failed to adequately test for these behavioral risks and neglected to properly warn patients and healthcare providers about the potential consequences. The plaintiffs further alleged that the manufacturers concealed these harmful side effects, resulting in severe personal, emotional, and financial damage to patients and their families.
Otsuka Canada and Lundbeck Canada agreed to the $4.75-million settlement to resolve the lawsuit nationwide. Both companies deny all allegations and have admitted no wrongdoing or legal liability, with the court making no final ruling on the merits of the case.
Who Is Eligible to File a Claim?
To participate in the settlement and receive a financial payout, class members must meet specific criteria outlined in the court-approved agreement.
You may be eligible to file a claim if you meet all of the following requirements:
- Prescription Timeline: You were prescribed and ingested Rexulti in Canada between February 16, 2017, and August 23, 2025.
- Duration of Use: You took Rexulti for a minimum period of one month or longer.
- Onset of Symptoms: You developed one or more compulsive behaviors or impulse control disorders (compulsive gambling, hypersexuality, binge eating, or compulsive shopping/spending) while taking the medication or within three months of stopping it.
- Timely Submission: You submit a fully completed claim package along with required supporting evidence—such as pharmacy records, medical files, proof of financial harm, gambling records, or employment records—on or before July 27, 2026.
Family members, dependents, heirs, and estates of deceased individuals who met these conditions may also be entitled to compensation.
How Much Could Claimants Receive?
Compensation amounts vary based on the nature and severity of the harm suffered, with payouts split into two primary categories: psychological harm and financial loss. Eligible claimants can receive funds from both categories if they provide appropriate documentation.
Psychological Harm Payments
Compensation under this tier requires documentary evidence of a prescription, signed attestations, and treating medical records. Depending on the severity rating assessed by the claims administrator, estimated payouts include:
- Mild cases: $6,531.25
- Moderate cases: $29,687.50
- Severe cases: $102,600
- Catastrophic cases: $71,250
Financial Loss and Family Claims
A dedicated pool of $570,000 has been set aside for claimants who can demonstrate direct financial consequences linked to impulse control issues caused or worsened by Rexulti. This covers documented loss of income or employment, out-of-pocket gambling losses, and debts or loans incurred due to compulsive gambling.
Additionally, family members of eligible class members can claim a percentage of the primary payment awarded for psychological harm, subject to an aggregate compensation cap of $199,500.
The remainder of the total $4.75 million fund is allocated toward court-approved legal fees ($1.425 million), public health insurer claims ($118,750), and claims administration costs ($55,000).
Here’s My Take: Why This Settlement Hits Harder Than Most Medical Class Actions
Here’s what stands out to me about this case: pharmaceutical lawsuits often focus on physical side effects like organ damage or surgical complications. But impulse control disorders hit people in a uniquely devastating way because they quietly dismantle a person’s financial stability, relationships, and personal reputation.
Imagine taking a prescribed medication to manage depression or mental health, only to find yourself inexplicably developing a gambling addiction or spending life savings away—without realizing the prescription bottle in your cabinet could be driving the behavior. The psychological toll of believing you are losing control of your own choices is immense.
What makes this final claim deadline so critical is that many affected patients may have blamed themselves for their sudden behavioral shifts rather than suspecting a prescription drug side effect. If you or someone you care about noticed a drastic, unexplained turn toward compulsive spending, gambling, or bingeing while taking Rexulti, taking a moment to examine medical and pharmacy records right now could bring both legal closure and significant financial relief.
What You Need to Do Next Before the Deadline
The clock is ticking, and missing Monday’s deadline means forfeiting your right to claim any portion of the settlement.
Here are the concrete steps to take immediately:
- Gather Documents: Locate your pharmacy dispensing records proving you took Rexulti between February 16, 2017, and August 23, 2025. Request relevant medical files, therapy records, or financial documentation (such as bank statements or gambling records) that substantiate impulse control behavior.
- Obtain the Claim Package: Download the official claim forms directly from the court-appointed claims administrator, MNP Ltd., or access them through the designated settlement website (
rexulticlassactionsettlement.com). - Submit on Time: Completed claim packages must be fully filled out and either electronically submitted or postmarked no later than Monday, July 27, 2026.
Once submitted, MNP Ltd. will review all documentation to determine eligibility and compensation levels. An official appeal procedure will be available for claimants who disagree with the administrator’s initial assessment.
Leave a Reply